<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://www.fda.gov/oc/datacouncil/stylesheets/spl/spl.xsl" type="text/xsl"?><document xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 http://www.fda.gov/oc/datacouncil/schemas/spl/spl.xsd">
<id root="30AF60ED-4D7F-FBD1-9DFD-AB2F32F6A004" />
<code code="34391-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="HUMAN PRESCRIPTION DRUG LABELING" />
<title ID="INV-f7c77fbc-b114-409f-8ef4-cbf83de9e852" mediaType="text/x-hl7-title+xml">Potassium Chloride Injection<br />in Plastic
        Container<br />Ready To Use<br />Viaflex&#174; Plus Container</title>
<effectiveTime value="20060309" />
<setId root="092ddee4-572d-4771-8d95-880cea01097e" />
<versionNumber value="1" />
<author>
<time />
<assignedEntity>
<representedOrganization>
<name>Baxter Healthcare Corporation</name>
</representedOrganization>
</assignedEntity>
</author>
<component>
<structuredBody>
<component>
<section>
<id root="2260B7C4-491C-F313-4653-0D04CAA184AF" />
<effectiveTime value="20060309" />
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0705" codeSystem="2.16.840.1.113883.6.69" />
<name>Potassium Chloride</name>
<formCode code="C42899" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION, CONCENTRATE" />
<activeIngredient>
<quantity>
<numerator unit="meq" value="10">
<translation code="C48512" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIEQUIVALENT" value="10" />
</numerator>
<denominator unit="mL" value="50">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="50" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Potassium Chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="50">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="50" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0705-41" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0709" codeSystem="2.16.840.1.113883.6.69" />
<name>Potassium Chloride</name>
<formCode code="C42899" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION, CONCENTRATE" />
<activeIngredient>
<quantity>
<numerator unit="meq" value="10">
<translation code="C48512" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIEQUIVALENT" value="10" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Potassium Chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0709-48" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0703" codeSystem="2.16.840.1.113883.6.69" />
<name>Potassium Chloride</name>
<formCode code="C42899" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION, CONCENTRATE" />
<activeIngredient>
<quantity>
<numerator unit="meq" value="20">
<translation code="C48512" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIEQUIVALENT" value="20" />
</numerator>
<denominator unit="mL" value="50">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="50" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Potassium Chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="50">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="50" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0703-41" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0705" codeSystem="2.16.840.1.113883.6.69" />
<name>Potassium Chloride</name>
<formCode code="C42899" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION, CONCENTRATE" />
<activeIngredient>
<quantity>
<numerator unit="meq" value="20">
<translation code="C48512" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIEQUIVALENT" value="20" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Potassium Chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0705-48" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0707" codeSystem="2.16.840.1.113883.6.69" />
<name>Potassium Chloride</name>
<formCode code="C42899" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION, CONCENTRATE" />
<activeIngredient>
<quantity>
<numerator unit="meq" value="30">
<translation code="C48512" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIEQUIVALENT" value="30" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Potassium Chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0707-48" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0703" codeSystem="2.16.840.1.113883.6.69" />
<name>Potassium Chloride</name>
<formCode code="C42899" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION, CONCENTRATE" />
<activeIngredient>
<quantity>
<numerator unit="meq" value="40">
<translation code="C48512" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIEQUIVALENT" value="40" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Potassium Chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0703-48" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
</section>
</component>
<component>
<section ID="INV-fef021c8-2818-41a1-b42c-486d34cd5a8a">
<id root="820C3359-3D8E-E6D9-B2DD-5CB88499E313" />
<code code="34089-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="DESCRIPTION SECTION" />
<title ID="INV-44d6f724-629e-4ca6-ac5f-a85f60f2ac6f" mediaType="text/x-hl7-title+xml">DESCRIPTION</title>
<text ID="INV-d4e74757-d19a-4d8f-895a-ce3bdfcc46d2"><paragraph ID="INV-cce04967-3966-42b7-b1f1-ed51c77260e4">This Potassium
                            Chloride Injection, is a sterile, nonpyrogenic, highly concentrated,
                            ready-to-use, solution of Potassium Chloride, USP in Water for
                            Injection, USP for electrolyte replenishment in a single dose container
                            for intravenous administration. It contains no antimicrobial agents.</paragraph><table frame="void"><col align="left" width="150pt" />
<col align="left" width="150pt" />
<col align="left" width="150pt" />
<col align="left" width="100pt" />
<col align="left" width="75pt" />
<col align="left" width="75pt" />
<thead valign="bottom">
<tr valign="bottom"><td align="left" rowspan="2" styleCode="Botrule                                         Rrule" valign="bottom">Potassium Chloride Injection mEq Potassium/Container</td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="bottom">Composition(g/L) Potassium Chloride, USP(KCl)</td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="bottom">Osmolarity<footnote ID="INV-62c16e37-2a82-44bd-a49b-713ca03aa273">Normal
                                            physiologic osmolarity range is approximately 280 to 310
                                            mOsmol/L. Administration of substantially hypertonic                                        solutions (&#8805;600 mOsmol/L) may cause vein
                                        damage.</footnote><br />mOsmol/L)(calc)</td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="bottom">pH</td><td align="center" colspan="2" styleCode="Botrule                                         Rrule" valign="bottom">Ionic Concentration(mEq/L)</td></tr>
<tr valign="bottom"><td align="center" styleCode="Botrule Rrule" valign="bottom">Potassium</td><td align="center" styleCode="Botrule" valign="bottom">Chloride</td></tr>
</thead>
<tbody valign="top">
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">10
                                        mEq/100 mL</td><td align="center" styleCode="Botrule Rrule" valign="top">7.46</td><td align="center" styleCode="Botrule Rrule" valign="top">200</td><td align="center" styleCode="Botrule Rrule" valign="top">5.0 (4.0
                                        to 8.0)</td><td align="center" styleCode="Botrule Rrule" valign="top">100</td><td align="center" styleCode="toprule" valign="top">100</td></tr>
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">10
                                        mEq/50mL <br />20 mEq/100mL</td><td align="center" styleCode="Botrule Rrule" valign="middle">14.9</td><td align="center" styleCode="Botrule Rrule" valign="middle">400</td><td align="center" styleCode="Botrule Rrule" valign="middle">5.0 (4.0
                                        to 8.0)</td><td align="center" styleCode="Botrule Rrule" valign="middle">200</td><td align="center" styleCode="toprule" valign="middle">200</td></tr>
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">30
                                        mEq/100 mL</td><td align="center" styleCode="Botrule Rrule" valign="top">22.4</td><td align="center" styleCode="Botrule Rrule" valign="top">601</td><td align="center" styleCode="Botrule Rrule" valign="top">5.0 (4.0
                                        to 8.0)</td><td align="center" styleCode="Botrule Rrule" valign="top">300</td><td align="center" styleCode="toprule" valign="top">300</td></tr>
<tr valign="top"><td align="left" styleCode="Rrule" valign="top">20 mEq/50 mL <br />40
                                        mEq/100 mL</td><td align="center" styleCode="Rrule" valign="middle">29.8</td><td align="center" styleCode="Rrule" valign="middle">799</td><td align="center" styleCode="Rrule" valign="middle">5.0 (4.0 to 8.0)</td><td align="center" styleCode="Rrule" valign="middle">400</td><td align="center" styleCode="toprule" valign="middle">400</td></tr>
</tbody>
</table><paragraph ID="INV-1ce7857e-dbcf-4867-870f-621e5b2b3436">This Viaflex&#174; Plus
                            plastic container is fabricated from a specially formulated polyvinyl
                            chloride (PL 146&#174; Plastic). Exposure to temperatures above 25&#176;C/77&#176;F
                            during transport and storage will lead to minor losses in moisture
                            content. Higher temperatures lead to greater losses. It is unlikely that
                            these minor losses will lead to clinically significant changes within
                            the expiration period. The amount of water that can permeate from inside
                            the container into the overwrap is insufficient to affect the solution
                            significantly. Solutions in contact with the plastic container may leach
                            out certain of its chemical components from the plastic in very small
                            amounts; however, biological testing was supportive of the safety of the
                            plastic container materials.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-0ac2e012-a88d-42e8-9b18-e756de3549ef">
<id root="A99627DF-81A5-0F88-2846-BE8CC44D0FAE" />
<code code="34090-1" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CLINICAL PHARMACOLOGY SECTION" />
<title ID="INV-a50c7eae-3b33-487a-986a-b306e4f5e8e1" mediaType="text/x-hl7-title+xml">CLINICAL PHARMACOLOGY</title>
<text ID="INV-b208a064-c77a-466f-85a0-c3d5a291ce83"><paragraph ID="INV-ecb859c6-1e83-4ed2-984a-873111530618">Potassium is the
                            major cation of body cells (160 mEq/liter of intracellular water) and is
                            concerned with the maintenance of the body fluid composition and
                            electrolyte balance. Potassium participates in carbohydrate utilization,
                            protein synthesis, and is critical in the regulation of nerve conduction
                            and muscle contraction, particularly in the heart. Chloride, the major
                            extracellular anion, closely follows the metabolism of sodium, and
                            changes in the acid-base of the body are reflected by changes in the
                            chloride concentration.</paragraph><paragraph ID="INV-22c398ad-ee78-4157-b650-1bd4457d19f2">Normally about 80
                            to 90% of the potassium intake is excreted in the urine, the remainder
                            in the stools and to a small extent, in the perspiration. The kidney
                            does not conserve potassium well so that during fasting, or in patients
                            on a potassium-free diet, potassium loss from the body continues
                            resulting in potassium depletion. A deficiency of either potassium or
                            chloride will lead to a deficit of the other.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-b95cd071-68eb-464d-9cda-265717ebefad">
<id root="8BA96200-9A7F-16F7-70C2-09CAB41B73A6" />
<code code="34067-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="INDICATIONS AND USAGE SECTION" />
<title ID="INV-3823088a-e84a-4378-bbaa-70caa047daae" mediaType="text/x-hl7-title+xml">INDICATIONS AND USAGE</title>
<text ID="INV-ee23fb90-4b35-4923-a586-ba23c102ecc5"><paragraph ID="INV-ce54cc03-ed54-434a-ba16-f043f61602e3">Potassium Chloride
                            Injection is indicated in the treatment of potassium deficiency states
                            when oral replacement is not feasible.</paragraph><paragraph ID="INV-55924f48-8dbf-41d2-9593-7161cd8d1ff8"><content styleCode="bold">THIS HIGHLY CONCENTRATED, READY-TO-USE
                                POTASSIUM CHLORIDE INJECTION IS INTENDED FOR THE MAINTENANCE OF
                                SERUM K+ LEVELS AND FOR POTASSIUM SUPPLEMENTATION IN FLUID
                                RESTRICTED PATIENTS WHO CANNOT ACCOMMODATE ADDITIONAL VOLUMES OF
                                FLUID ASSOCIATED WITH POTASSIUM SOLUTIONS OF LOWER
                            CONCENTRATION.</content></paragraph><paragraph ID="INV-111b18fa-63f8-4e24-a351-42afbe1e0c73">When using these
                            products, these patients should be on continuous cardiac monitoring and
                            frequent testing for serum potassium concentration and acid-base
                            balance.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-68fbb4d2-7524-4f6b-baa8-39f5aa9015d4">
<id root="52C028B2-1D14-BEA3-BD8A-98EDD55720A2" />
<code code="34070-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CONTRAINDICATIONS SECTION" />
<title ID="INV-d59be417-497a-4538-be80-fcc27efbf081" mediaType="text/x-hl7-title+xml">CONTRAINDICATIONS</title>
<text ID="INV-8df748dc-a2c8-4e6f-afe0-ed979cd2d1fe"><paragraph ID="INV-380aa528-46af-43c1-b904-d654b835ea8c">Potassium Chloride
                            Injection is contraindicated in diseases where high potassium levels may
                            be encountered, and in patients with hyperkalemia, renal failure and inconditions in which potassium retention is present.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-4b3441b4-441c-4326-b43a-a1d65e3e3a6a">
<id root="CFD7891E-9CA5-83E2-EA92-77D077B2078C" />
<code code="34071-1" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="WARNINGS SECTION" />
<title ID="INV-2d956291-4b24-4962-af5f-135861c7a5f6" mediaType="text/x-hl7-title+xml">WARNINGS</title>
<text ID="INV-fdce1715-5755-4000-8fa8-664171a2a106"><paragraph ID="INV-663f879c-64e7-4da1-9c4d-530dc4126d77"><content styleCode="bold">THIS HIGHLY CONCENTRATED, READY-TO-USE
                                POTASSIUM CHLORIDE INJECTION IS INTENDED FOR THE MAINTENANCE OF
                                SERUM K+ LEVELS AND FOR POTASSIUM SUPPLEMENTATION IN FLUID
                                RESTRICTED PATIENTS WHO CANNOT ACCOMMODATE ADDITIONAL VOLUMES OF
                                FLUID ASSOCIATED WITH POTASSIUM SOLUTIONS OF LOWER
                            CONCENTRATION.</content></paragraph><paragraph ID="INV-847def91-9b3a-475f-9dda-204db06d8b34"><content styleCode="bold">TO AVOID POTASSIUM INTOXICATION, DO NOT INFUSE
                                THESE SOLUTIONS RAPIDLY. PATIENTS REQUIRING HIGHLY CONCENTRATED
                                SOLUTIONS SHOULD BE KEPT ON CONTINUOUS CARDIAC MONITORING AND
                                UNDERGO FREQUENT TESTING FOR SERUM POTASSIUM AND ACID-BASE BALANCE,
                                ESPECIALLY IF THEY RECEIVE DIGITALIS.</content></paragraph><paragraph ID="INV-8f3ced9f-4205-4947-ab8b-4d8340538bad">In patients with
                            renal insufficiency, administration of potassium chloride may cause
                            potassium intoxication and life-threatening hyperkalemia.</paragraph><paragraph ID="INV-1e267891-db29-46b3-8745-a61cd3acb33c"><content styleCode="bold">Administer intravenously only with a
                                calibrated infusion device at a slow, controlled rate. (See Dosage
                                and Administration). Because pain associated with peripheral
                                infusion of Potassium Chloride solution has been reported, whenever
                                possible, administration via a central route is recommended for
                                thorough dilution by the blood stream and avoidance of
                                extravasation. Highest concentrations (300 and 400 mEq/L) should be
                                exclusively administered via central route.</content></paragraph><paragraph ID="INV-b1120b8e-c6db-4558-ba19-4d91a6899331">The administration
                            of intravenous solutions can cause fluid and/or solute overload
                            resulting in dilution of serum electrolyte concentrations,
                            overhydration, congested states or pulmonary edema. The risk of
                            dilutional states is inversely proportional to the electrolyte
                            concentration. The risk of solute overload causing congested states with
                            peripheral and pulmonary edema is directly proportional to the
                            electrolyte concentration.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-9d6cccc0-43ba-4bb8-90a2-d251925829ab">
<id root="E6A00751-C22F-061D-9501-BB8B349F1B19" />
<code code="42232-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PRECAUTIONS SECTION" />
<title ID="INV-2bd90362-786f-48a3-b609-f405b3fc3aa5" mediaType="text/x-hl7-title+xml">PRECAUTIONS</title>
<effectiveTime value="20060309" />
<component>
<section ID="INV-34b6e2ac-90c3-4d68-b1d3-70bcb1bb8937">
<id root="BB539F5F-5CF9-D3E3-1618-6CDF896EAA0D" />
<code code="34075-2" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="LABORATORY TESTS SECTION" />
<title ID="INV-938f48ca-52bc-4719-9c90-334b153b6271" mediaType="text/x-hl7-title+xml">Laboratory Tests</title>
<text ID="INV-272a78db-30c1-4de3-9ff8-db2cb2efec3f"><paragraph ID="INV-32230c75-b6f8-4a24-8395-bef7989ad719">Serum
                                    potassium levels are not necessarily indicative of tissue
                                    potassium levels. Solutions containing potassium should be used
                                    with caution in the presence of cardiac or renal disease.</paragraph><paragraph ID="INV-42831dc2-bd89-4a2a-9b32-361b07ce0a44">Clinical
                                    evaluation and periodic laboratory determinations are necessary
                                    to monitor changes in fluid balance, electrolyte concentrations,
                                    and acid-base balance during prolonged parenteral therapy or
                                    whenever the condition of the patient warrants such evaluation.
                                    Significant deviations from normal concentrations may require
                                    the use of additional electrolyte supplements, or the use of
                                    electrolyte-free dextrose solutions to which individualized
                                    electrolyte supplements may be added.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-24e3a62e-bc38-4225-9c0a-d80890dee202">
<id root="3751CC45-8685-D6C7-2E6F-511FC564E201" />
<code code="42228-7" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PREGNANCY" />
<title ID="INV-c1481af6-5027-435a-b5ef-dbdfbb0f80aa" mediaType="text/x-hl7-title+xml">Pregnancy</title>
<effectiveTime value="20060309" />
<component>
<section ID="INV-e1901b3e-035b-4782-9117-3b1f53dfd9ee">
<id root="4F638651-6BAC-D3C4-5FBF-E651AB8807C5" />
<title ID="INV-482c69c6-2906-4d96-a58f-4ac6612f7edd" mediaType="text/x-hl7-title+xml">Pregnancy
                                        Category C</title>
<text ID="INV-00b165d9-f220-41c0-b6b4-587c37d5c55c"><paragraph ID="INV-7d8dfc6b-1ad8-4893-b4a3-7616e6dc192c">Animal reproduction studies have not been conducted                 with potassium chloride. It is also not known whether
                                            potassium chloride can cause fetal harm when
                                            administered to a pregnant woman or can affect
                                            reproduction capacity. Potassium chloride should be
                                            given to a pregnant woman only if clearly
                                        needed.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
</section>
</component>
<component>
<section ID="INV-b9ae69dd-76b5-4061-a02a-1a730d0984aa">
<id root="EEB6E7C0-5694-CE20-4C22-DC134D8335A7" />
<code code="34081-0" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PEDIATRIC USE SECTION" />
<title ID="INV-f2397ef4-fd05-4620-a039-e7d7aebfd58c" mediaType="text/x-hl7-title+xml">Pediatric Use</title>
<text ID="INV-59c9ae6e-63fe-4c44-8fd1-619eb6e9e9ad"><paragraph ID="INV-fb620384-283f-4f99-aa94-f492d84191af">These
                                    products should not be used in children at this time.</paragraph><paragraph ID="INV-c67b1032-d195-4016-9b9a-f262c6bb633d">Do not
                                    administer unless solution is clear and seal is
                                intact.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
</section>
</component>
<component>
<section ID="INV-24f7f0de-944c-41bb-8f86-1d89238e4ac8">
<id root="A03CEC38-EFF3-DB35-DDE4-401992137372" />
<code code="34084-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="ADVERSE REACTIONS SECTION" />
<title ID="INV-1fcf4f8c-1cc8-4886-8555-298f632e107a" mediaType="text/x-hl7-title+xml">ADVERSE REACTIONS</title>
<text ID="INV-e27cc248-d40d-43fa-86b0-d295642f24d7"><paragraph ID="INV-d2291e8a-5c77-4583-8d70-dc820f19b9b8">Potassium
                            intoxication with mild or severe hyperkalemia has been reported. The
                            signs and symptoms of intoxication include, paresthesia of the
                            extremities, areflexia, muscular or respiratory paralysis, mental
                            confusion, weakness, hypotension, cardiac arrhythmia, heart block,
                            electrographic abnormalities and cardiac arrest. EKG abnormalities serve
                            as a clinical reflection of the seriousness of changes in serum
                            potassium concentrations; peaked T waves and prolonged P-R intervals
                            usually occur with modest elevations above the upper limit of normal
                            potassium concentrations; P waves disappear, the QRS complex widens, and
                            eventual asystole usually occurs with higher elevations.</paragraph><paragraph ID="INV-60b75e67-4e19-4b75-ad18-cb0b7996cd00">Reactions which may
                            occur because of the solution or the technique of administration include
                            febrile response, infection at the site of injection, venous thrombosis
                            or phlebitis extending from the site of injection, extravasation and
                            hypervolemia.</paragraph><paragraph ID="INV-f9516fcf-a666-4414-a028-28e1c9dd6c3f">Infusion of highly
                            concentrated potassium chloride solutions may cause local pain and vein                   irritation. (See <linkHtml ID="INV-b76a3fba-5b02-42e1-b5d7-af3ed8cdf0f3" href="#INV-663f879c-64e7-4da1-9c4d-530dc4126d77">WARNINGS</linkHtml>).</paragraph><paragraph ID="INV-85a57655-f8af-4191-80a1-106842f671fe">Reactions reported
                            with the use of potassium-containing solutions include nausea, vomiting,
                            and abdominal pain and diarrhea.</paragraph><paragraph ID="INV-0c20e9e3-1b9b-498d-9d9a-9ae12508693b">If an adverse
                            reaction does occur, discontinue the infusion, evaluate the patient,                      institute appropriate therapeutic countermeasures and save the remainder
                            of the fluid for examination if deemed necessary.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-be9979ee-7e6a-4801-aa68-9444968f908e">
<id root="586C77AB-ADDE-FC76-1F78-DBE7D308E0B5" />
<code code="34088-5" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="OVERDOSAGE SECTION" />
<title ID="INV-5b9303e1-5bf3-4217-b05a-a4bce4597d54" mediaType="text/x-hl7-title+xml">OVERDOSAGE</title>
<text ID="INV-2f81723d-ead5-4cc1-807f-9eecb1796c13"><paragraph ID="INV-4f01c32d-a236-4360-9f6b-fa6ce8ad4db5">In the event of
                            hyperkalemia, discontinue the infusion immediately and institute
                            corrective therapy to reduce serum potassium levels as necessary. The
                            use of potassium containing foods or medications must also be
                            eliminated.</paragraph><paragraph ID="INV-03cdaf97-5d3e-43c7-b5be-faef13563d41">Treatment of mild
                            to severe hyperkalemia with signs and symptoms of potassium intoxication
                            includes the following:</paragraph><paragraph ID="INV-d8b6c807-9cf4-4e28-976c-99d5c464bda2">1. Dextrose
                            Injection, USP, 10% or 25%, containing 10 units of crystalline insulin
                            per 20 grams of dextrose administered intravenously, 300 to 500 mL per
                            hour.</paragraph><paragraph ID="INV-8aeeb6b7-1293-46b7-b5f8-4c79a5ba932c">2. Absorption and
                            exchange of potassium using sodium or ammonium cycle cation exchange
                            resin, orally and as retention enema.</paragraph><paragraph ID="INV-2ca7821f-61c8-4d71-8c5b-a2a59db1f1c6">3. Hemodialysis and
                            peritoneal dialysis.</paragraph><paragraph ID="INV-06b90ecf-afc0-4a56-a3b2-e9596a32f2d3">In cases of                            digitalization, too rapid a lowering of plasma potassium concentration
                            can cause digitalis toxicity.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-af3aec1c-2d84-48e8-b6aa-d91eaa8abf5f">
<id root="DA838F76-4C74-8FC0-2A95-547095B90812" />
<code code="34068-7" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="DOSAGE AND ADMINISTRATION SECTION" />
<title ID="INV-ba6bdb6b-277e-4c34-8101-d33a94998b64" mediaType="text/x-hl7-title+xml">DOSAGE AND ADMINISTRATION</title>
<text ID="INV-a0c32e81-b00f-4e41-aa1a-8dec60b2a927"><paragraph ID="INV-7d8e6c7d-5342-4a89-9de8-e3015abb3fe8">The dose and rate
                            of administration are dependent upon the specific condition of each
                            patient.</paragraph><paragraph ID="INV-4d175643-d900-4eed-9b5c-55643465ba18"><content styleCode="bold">Administer Intravenously only with a
                                calibrated infusion device at a slow, controlled rate. Because pain
                                associated with peripheral infusion of Potassium Chloride solution
                                has been reported, whenever possible, administration via a central
                                route is recommended for thorough dilution by the blood stream and
                                avoidance of extravasation. Highest concentrations (300 and 400
                                mEq/L) should be exclusively administered via central
                            route.</content></paragraph><paragraph ID="INV-c7e64849-162d-4e21-b363-8e1928327f01">Recommended
                            administration rates should not usually exceed 10mEq/hour or 200mEq for
                            a 24 hour period if the serum potassium level is greater than 2.5
                            mEq/liter.</paragraph><paragraph ID="INV-e15c0772-a614-444d-a3ae-940cb3a0fb06">In urgent cases
                            where the serum potassium level is less than 2.0 mEq/liter or where
                            severe hypokalemia is a threat, (serum potassium level less than 2.0
                            mEq/liter and electrocardiographic changes and/or muscle paralysis)
                            rates up to 40 mEq/hour or 400 mEq over a 24 hour period can be
                            administered very carefully when guided by continuous monitoring of the
                            EKG and frequent serum K+ determinations to avoid hyperkalemia and
                            cardiac arrest.</paragraph><paragraph ID="INV-bef6368d-e2ee-4e2b-9b92-2753522364d5">Parenteral drug
                            products should be inspected visually for particulate matter and
                            discoloration, whenever solution and container permit. Use of a final
                            filter is recommended during administration of all parenteral solutions
                            where possible.<br /><br />Do not add supplementary medication.</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-de42845e-d4c0-47e2-8d3d-3d73234e7403">
<id root="13D64889-9C96-721C-43A5-16DDE512AC32" />
<code code="34069-5" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="HOW SUPPLIED SECTION" />
<title ID="INV-6c3edfb7-59b2-4023-a031-356d18b56785" mediaType="text/x-hl7-title+xml">HOW SUPPLIED</title>
<text ID="INV-c6201298-2392-4921-b4ec-37f50f227667"><paragraph ID="INV-2759857f-6436-4de0-afd3-1b2bc7c569d8">Potassium Chloride
                            Injection in Viaflex&#174; Plus plastic containers is available as follows:</paragraph><table frame="void"><col align="left" width="100pt" />
<col align="left" width="150pt" />
<col align="left" width="150pt" />
<thead valign="bottom">
<tr valign="bottom"><td align="left" styleCode="Botrule Rrule" valign="bottom" /><td align="left" styleCode="Botrule Rrule" valign="bottom" /><td align="left" styleCode="Botrule" valign="bottom" /></tr>
</thead>
<tbody valign="top">
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">2B0826</td><td align="center" styleCode="Botrule Rrule" valign="top">10
                                        mEq/100 mL</td><td align="center" styleCode="toprule" valign="top">NDC
                                        0338-0709-48</td></tr>
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">2B0821</td><td align="center" styleCode="Botrule Rrule" valign="top">10
                                        mEq/50 mL</td><td align="center" styleCode="toprule" valign="top">NDC
                                        0338-0705-41</td></tr>
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">2B0827</td><td align="center" styleCode="Botrule Rrule" valign="top">20
                                        mEq/100 mL</td><td align="center" styleCode="toprule" valign="top">NDC
                                        0338-0705-48</td></tr>
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">2B0823</td><td align="center" styleCode="Botrule Rrule" valign="top">30
                                        mEq/100 mL</td><td align="center" styleCode="toprule" valign="top">NDC
                                        0338-0707-48</td></tr>
<tr valign="top"><td align="left" styleCode="Botrule Rrule" valign="top">2B0822</td><td align="center" styleCode="Botrule Rrule" valign="top">20
                                        mEq/50 mL</td><td align="center" styleCode="toprule" valign="top">NDC
                                        0338-0703-41</td></tr>
<tr valign="top"><td align="left" styleCode="Rrule" valign="top">2B0824</td><td align="center" styleCode="Rrule" valign="top">40 mEq/100 mL</td><td align="center" styleCode="toprule" valign="top">NDC 0338-0703-48</td></tr>
</tbody>
</table><paragraph ID="INV-c6f13d59-5bc4-47ee-bbad-b8aa5796f90a">Exposure of
                            pharmaceutical products to heat should be minimized.&amp; Avoid
                            excessive heat.&amp; It is recommended that this product be stored
                            at room temperature (25&#176;C).</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-3976aa1e-a749-4993-97df-e4816079c402">
<id root="0593F1CB-1B36-001E-0174-A9ED6CE5B4A1" />
<title ID="INV-190848c1-5d7f-4974-8bed-ed759bba3503" mediaType="text/x-hl7-title+xml">DIRECTIONS FOR USE OF
                        VIAFLEX&#174; PLUS PLASTIC CONTAINER</title>
<text ID="INV-ae4a991a-c1c5-4b45-8272-1716db4052d8"><paragraph ID="INV-35ac54cf-93fd-480d-b51b-23b9d03809a9">Do not use plastic
                            containers in series connections. Such use could result in air embolism
                            due to residual air being drawn from the primary container before
                            administration of the fluid from the secondary container is      completed.</paragraph></text>
<effectiveTime value="20060309" />
<component>
<section ID="INV-7bb5478e-1da1-4597-85fc-ef2e051bf19a">
<id root="C584300F-2916-EF8D-2D18-61090D1D9C3E" />
<title ID="INV-9c6d1fe9-be45-463a-bf64-e5e156c6bb0f" mediaType="text/x-hl7-title+xml">TO OPEN</title>
<text ID="INV-8d2dfa23-dee8-4dd9-ba1e-82e7c18308a1"><paragraph ID="INV-d5498507-114a-4701-ac54-40e5e2be397f">Tear
                                    overwrap down side at slit and remove solution container. Some
                                    opacity of the plastic due to moisture absorption during the
                                    sterilization process may be observed. This is normal and does
                                    not affect the solution quality or safety. The opacity will
                                    diminish gradually. Check for minute leaks by squeezing inner
                                    bag firmly. If leaks are found, discard solution as sterility
                                    may be impaired. <content styleCode="bold">Do not add                    supplementary medication.</content></paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
<component>
<section ID="INV-9f5523f9-a7fa-4dba-a567-ff39f2d952cc">
<id root="53A33442-B776-6FFD-29E4-DF8154099EED" />
<title ID="INV-413af269-d45f-4ee4-ba0f-57175ccd8b96" mediaType="text/x-hl7-title+xml">PREPARATION FOR
                                ADMINISTRATION</title>
<text ID="INV-6ea74d11-bfb7-44e3-abe0-84e2359b41eb"><paragraph ID="INV-0237ee0b-1a6d-4110-8b90-61d8112fb4c4">1. Suspend
                                    container from eyelet support.</paragraph><paragraph ID="INV-850c0a4b-dcc3-4527-8215-868cf39d2e46">2. Remove
                                    plastic protector from outlet port at bottom of container.</paragraph><paragraph ID="INV-8bc52bf5-f40f-4e3c-a534-7f06ff461b98">3. Attach
                                    administration set. Refer to complete directions accompanying
                                    set.</paragraph><paragraph ID="INV-ad3f1e73-4a0b-4016-a6b0-f38f2b575040"><content styleCode="bold">Baxter Healthcare
                                    Corporation</content></paragraph><paragraph ID="INV-797490d4-4f10-446b-a417-8688a10a2216">Deerfield,
                                    IL 60015 USA</paragraph><paragraph ID="INV-12183f7d-77a2-45cc-9378-e51b7d002cc7">Printed in
                                    USA</paragraph></text>
<effectiveTime value="20060309" />
</section>
</component>
</section>
</component>
</structuredBody>
</component>
</document>
